A Phase 1 Clinical Trial of CHT-25 a 1131l-Labeled Chimeric Anti-CD25Antibody Showing Efficacy in Patients with Refractory Lymphoma

G Dancey, J. Violet, A.J. Malaroda, S.K. Sharma, Roslyn Francis, S. Othman, S. Parker, J. Buscombe, N. Griffen, P. Chan, A. Malhotra, N. Woodward, A. Ramsay, P. Ross, T.A. Lister, P. Amlot, R. Begent, C. Mcnamara

    Research output: Contribution to journalArticlepeer-review

    29 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)7701-7710
    JournalClinical Cancer Research
    Publication statusPublished - 2009

    Cite this